Publicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (26)

2024

  1. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

  2. Descriptive study on substance uses and risk of sexually transmitted infections in the practice of Chemsex in Spain

    Frontiers in Public Health, Vol. 12

2023

  1. ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482

  2. Burden of refractory and unexplained chronic cough on patients’ lives: a cohort study

    ERJ Open Research, Vol. 9, Núm. 5

  3. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study

    Lung, Vol. 201, Núm. 3, pp. 275-286

  4. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  5. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13

  6. Role of Different Health Care Professionals in the Management of Asthma Patients: The GEMA-FORUM IV Task Force

    Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 3, pp. 214-217

2022

  1. Severity and duration of allergic conjunctivitis: are they associated with severity and duration of allergic rhinitis and asthma?

    European Annals of Allergy and Clinical Immunology, Vol. 54, Núm. 6, pp. 277-283

  2. Within-subject biological variation estimates using an indirect data mining strategy. Spanish multicenter pilot study (BiVaBiDa)

    Clinical Chemistry and Laboratory Medicine, Vol. 60, Núm. 11, pp. 1804-1812

2021

  1. Clinical, biological, and prognostic implications of SF3B1 co-occurrence mutations in very low/low- and intermediate-risk MDS patients

    Annals of Hematology, Vol. 100, Núm. 8, pp. 1995-2004

  2. Development of a Tool to Measure the Clinical Response to Biologic Therapy in Uncontrolled Severe Asthma: The FEV1, Exacerbations, Oral Corticosteroids, Symptoms Score

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2725-2731

  3. Real-life study in non-atopic severe asthma patients achieving disease control by omalizumab treatment

    Allergy: European Journal of Allergy and Clinical Immunology

2020

  1. Referral recommendations for adult emergency department patients with exacerbated asthma

    Emergencias, Vol. 32, Núm. 4, pp. 258-268

2019

  1. Defects in memory B-cell and plasma cell subsets expressing different immunoglobulin-subclasses in patients with CVID and immunoglobulin subclass deficiencies

    Journal of Allergy and Clinical Immunology, Vol. 144, Núm. 3, pp. 809-824

  2. Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

    Allergy: European Journal of Allergy and Clinical Immunology

2018

  1. Consensus document on dog and cat allergy

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 73, Núm. 6, pp. 1206-1222

2017

  1. Allergic respiratory disease: Different allergens, different symptoms

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 9, pp. 1306-1316

  2. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 72, Núm. 6, pp. 959-966

2015

  1. Consensus document on allergic conjunctivitis (DECA)

    Journal of Investigational Allergology and Clinical Immunology, Vol. 25, Núm. 2, pp. 94-106